Abstract
In a double-blind, randomised, comparative study, 44 healthy volunteers received alprazolam 0.5mg, buspirone 5mg or diazepam 5mg orally 3 times each day for 7 consecutive days. Daytime sedation was evaluated on the first and seventh treatment days by the multiple sleep latency test by direct EEG measurements. Sleep was recorded the night preceding each test day to control for the influence of sleep on subsequent daytime sedation and performance. A vigilance visual-tracking/reaction-time test was used to examine daytime performance, while other symptoms of daytime sedation were subjectively assessed by questionnaires. During treatment day 1, alprazolam- and diazepam-treated subjects were significantly sleepier than subjects who received buspirone. Compared with buspirone, performance was significantly impaired for the alprazolam subjects but not for the diazepam group. On day 7 differences in daytime sleepiness and sleep latency were no longer significant. However, alprazolam- and diazepam-treated subjects exhibited significantly slowed reaction times on the performance test. These results suggest that buspirone may have potential as an anxiolytic agent for patients in whom daytime alertness must not be compromised.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.